Hibsago (bepirovirsen)

Chronic hepatitis B virus infection in adults without cirrhosis

Also known as GSK3228836

Manufacturer: GSK
Regulatory status: ApprovedNDA submitted in the first quarter of 2026 and approved October 2026
Launch: Anticipated before the end of 2026
Last updated: October 22, 2026

Section

Product information and disease description Product description Product information

Dosing and administration

17 evidence topics · 4 sources